Amyloid-associated amyloidosis in a HCV carrier with non-Hodgkin's lymphoma who had been treated with autologous stem cell transplantation and rituximab.
Kubo
Yasutaka
Y
Tasaka
Taizo
T
Sano
Fuminori
F
Matsuhashi
Yoshiko
Y
Nishimura
Hirotake
H
Sadahira
Yoshito
Y
Wada
Hideho
H
Sugihara
Takashi
T
D000682:Amyloid / Q000378:metabolism; D000686:Amyloidosis / Q000175:diagnosis* / Q000821:virology*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects; D001706:Biopsy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007136:Immunoglobulins / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism; D008228:Lymphoma, Non-Hodgkin / Q000821:virology*; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000378:metabolism; D000069283:Rituximab; D013234:Stem Cells / Q000378:metabolism; D014182:Transplantation, Autologous
D000682:Amyloid; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007136:Immunoglobulins; D000069283:Rituximab